These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6977610)

  • 1. Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.
    Korngold R; Sprent J
    J Exp Med; 1982 Mar; 155(3):872-83. PubMed ID: 6977610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex.
    Korngold R; Sprent J
    Immunol Rev; 1983; 71():5-29. PubMed ID: 6221991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex.
    Korngold R; Sprent J
    J Exp Med; 1980 May; 151(5):1114-24. PubMed ID: 6966318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R; Sprent J
    J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.
    Sprent J; Schaefer M; Gao EK; Korngold R
    J Exp Med; 1988 Feb; 167(2):556-69. PubMed ID: 2964497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA; Soderling CC; Kersey JH
    J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte responses in allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the self-repertoire of Ia-restricted T cells but not H-2K/D-restricted T cells.
    Bradley SM; Kruisbeek AM; Singer A
    J Exp Med; 1982 Dec; 156(6):1650-64. PubMed ID: 6217271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens.
    Hamilton BL
    J Immunol; 1987 Oct; 139(8):2511-5. PubMed ID: 3498761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lethal graft-versus-host disease across minor histocompatibility barriers in mice.
    Korngold R; Sprent J
    Clin Haematol; 1983 Oct; 12(3):681-93. PubMed ID: 6416727
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
    Hamilton BL; Bevan MJ; Parkman R
    J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-2 restriction of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers in mice.
    Korngold R; Sprent J
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1217-9. PubMed ID: 7022928
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis.
    Hünig TR; Bevan MJ
    J Exp Med; 1982 Jan; 155(1):111-25. PubMed ID: 6976410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL; Charley MR; Calomeni JA; Lipsky PE
    J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin.
    Vallera DA; Youle RJ; Neville DM; Kersey JH
    J Exp Med; 1982 Mar; 155(3):949-54. PubMed ID: 6120991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. I. Negative selection across H-2 barriers induced with disrupted cells but not with glutaraldehyde-treated cells: evidence for antigen processing.
    Korngold R; Sprent J
    J Exp Med; 1980 Feb; 151(2):314-27. PubMed ID: 6766175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-2-Restricted lethal graft-versus-host diseases.
    Kindred B
    Immunogenetics; 1981 Dec; 14(6):527-33. PubMed ID: 6976318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.
    Korngold R; Sprent J
    J Exp Med; 1978 Dec; 148(6):1687-98. PubMed ID: 363972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both class I and class II responsive T cell subsets can separately initiate lethal graft-versus-host disease in H-2-incompatible murine radiation chimeras.
    Carmody L; Atkinson K; Cooley M; Chapman G; Biggs J; McKenzie I
    Transplant Proc; 1987 Apr; 19(2):2876-8. PubMed ID: 3105125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.